Sharemaestro Newsreel

Intuitive Surgical Inc. stock outperforms competitors on strong trading day

Intuitive Surgical Inc. (ISRG) saw its stock rise by 3.85% to $393.38 on a generally down day for the market. This performance outpaced major indices like the S&P 500 and Dow Jones Industrial Average, which experienced slight declines. It marked the second consecutive day …

New Product Launches and Strong Commercial Execution Drive Alcon's Second-Quarter 2026 Growth

Second-quarter 2026 sales of $2.8 billion, up 8%on a reported basis, or up 7% constant currency1 (cc), versus second-quarter 2025 Returned $538 million to shareholders through dividends and share repurchases on a year-to-date basis Updated full-year guidance - raised core operating margin and core …

Earnings Flash (ALC) Alcon Inc. Posts Q2 Adjusted EPS $0.84 per Share, vs. FactSet Est of $0.75

Alcon Inc. (ALC) announced its Q2 adjusted EPS of $0.84 per share, surpassing FactSet's estimate of $0.75. The company's Q2 revenue also exceeded expectations, reporting $2.78 billion against an estimated $2.76 billion. This financial news highlights a strong performance for the global ophthalmic care …

Bionano Genomics, Inc. Q2 2026: Revenue $8.17M, EPS $(0.64) — 10-Q Summary

Bionano Genomics, Inc. reported its Q2 2026 financial results, showing a 21% increase in revenue to $8.17M, up from $6.73M in Q2 2025. Despite this growth, the company recorded a net loss of $7.42M, though the diluted EPS improved significantly from $(1.99) to $(0.64) …

Bionano Reports Second Quarter 2026 Results and Provides a Business Update

Bionano has reported its second-quarter 2026 financial results, which include updates on its operational performance and strategic initiatives. The company also provided a comprehensive business update detailing its progress and future outlook.

Nephros (NEPH) boosts Q2 2026 profit on revenue growth and tariff refund

Nephros Inc. (NEPH) reported significant financial growth in Q2 2026, with net revenue up 36% to $6.0 million and net income rising to $1.2 million, largely driven by programmatic product growth and a $0.6 million IEEPA tariff refund. Despite this positive performance, the company …

AtriCure (ATRC) Lifted Its Guidance, Is The Stock Fully Priced?

AtriCure (ATRC) has seen insider share sales despite reporting 13% Q2 revenue growth, returning to net income, and raising full-year guidance. While one valuation narrative suggests the stock is 11.9% undervalued at $47.00 due to potential market expansion from clinical trials, another analysis using …

Embecta adds to earnings rally with another 9% advance (EMBC:NASDAQ)

Embecta Corp. (EMBC) shares climbed another 9% on Monday, extending a rally initiated by the medical device company's strong quarterly earnings release. This surge brings the total rally to over 26% since the previous session, driven by better-than-expected non-GAAP EPS and revenue, and raised …

4 Best PEG-Driven Value Stocks to Buy Now for Strong Returns

At a time when volatility strikes every second day, investors often rely on value investing rather than other options like growth or momentum. As soon as other investors start selling their stocks at a cheaper rate in times of market uncertainty, value investors take …

Intuitive Surgical Inc Stock (ISRG) Moved Up by 3.01% on Aug 10: A Full Analysis

Intuitive Surgical Inc (ISRG) stock increased by 3.01% on August 10, outperforming the Healthcare Services & Equipment sector. This rise is attributed to increased global procedure volumes, stable hospital capital expenditure, and strong institutional demand for its minimally invasive surgical platforms. Analysts maintain a …

Jim Cramer Sees Cheap Valuation in Becton, Dickinson (BDX) After Q3 Beat and Raised Guidance

On August 6, Jim Cramer highlighted Becton, Dickinson and Company (NYSE:BDX) on CNBC's Mad Money following its third-quarter fiscal 2026 financial report and said: This morning, we got a very strong quarter from BD. That's the big medical technology and supply play... That was …

Kestra Medical Technologies (NASDAQ:KMTS) Shares Up 8.2% - Here's What Happened

ResMed Inc. stock rises Monday, outperforms market

ResMed Inc. (RMD) stock rose 3.83% to $220.05 on Monday, outperforming a generally down market where the S&P 500 Index fell 0.06% and the Dow Jones Industrial Average dropped 0.11%. This gain ended a two-day losing streak for the company's shares.

Inogen Q2 Earnings Beat Estimates, Sales Rise Y/Y, 2026 View Cut

Inogen, Inc. INGN reported breakeven earnings for second-quarter 2026, compared to the year-ago period's adjusted loss of 2 cents per share. GAAP loss per share of 14 cents, narrower than the year-ago loss of 15 cents. The figure beat the Zacks Consensus Estimate by …

iRhythm Q2 Earnings Beat Estimates on Volume Growth, '26 View Raised

iRhythm Holdings, Inc. IRTC reported adjusted earnings per share of 58 cents in the second quarter of 2026, against an adjusted loss per share of 32 cents a year ago. The figure beat the Zacks Consensus Estimate by 5900%. GAAP loss per share for …

Weekly Recap: Azenta, Inc. Q3 revenue gain and analyst target raises

Azenta, Inc. (NASDAQ:AZTA) reported a strong Q3 with revenue up 12% year-over-year to $161.2M, driven by organic growth in Sample Management and Multiomics. The company announced a new buyback program, maintaining strong liquidity, and analysts subsequently raised price targets to $35 and $37 with …

Embecta Q3 results beat analyst expectations

Embecta Corp. (Nasdaq: EMBC) reported Q3 results that surpassed analyst expectations, leading the company to raise its full-year adjusted earnings per share outlook. The medtech firm, specializing in insulin delivery, posted net income of $21.1 million on $271.7 million in revenue, with adjusted EPS …

Pro-Dex Inc (PDEX) Positioned to Strengthen with Zimmer’s mBos Robot Commercialization

Long Cast Advisers, an independent registered investment adviser, released its Q2 2026 investor letter. A copy can be downloaded here. The firm reported strong earnings in the second quarter, with results improving 20%, bringing year-to-date returns to +19%. While performance trailed the Russell 2000 …

Perma Fix Environmental Services’ (PESI) Strong Backlog Overshadows Weak Results

Long Cast Advisers, an independent registered investment adviser, released its Q2 2026 investor letter. A copy can be downloaded here. The firm reported strong earnings in the second quarter, with results improving 20%, bringing year-to-date returns to +19%. While performance trailed the Russell 2000 …

First Trust Advisors LP Has $1.39 Million Stock Holdings in Envista Holdings Corporation $NVST

First Trust Advisors LP significantly reduced its stake in Envista Holdings Corporation (NYSE:NVST) by 79.5% in the first quarter, now holding 54,922 shares valued at $1.39 million. Envista reported strong quarterly earnings, beating analyst estimates with an EPS of $0.41 and a 7.1% revenue …

TFX vs. PEN: Which Stock Is the Better Value Option?

Investors interested in Medical - Instruments stocks are likely familiar with Teleflex (TFX) and Penumbra (PEN). But which of these two stocks presents investors with the better value opportunity right now? Let's take a closer look. We have found that the best way to …

Operating margin % of ResMed Inc. CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh – HAM:RMEA

This article provides the operating margin percentage for ResMed Inc. CHESS Depositary Interests (HAM:RMEA) on the Hamburg Stock Exchange. The information presented is for a specific period and includes the value, change, and percentage change of the operating margin. The data is sourced from …

OTLK Up More Than 300% in 3 Months: Here's What You Should Know

Shares of Outlook Therapeutics OTLK have witnessed a significant surge over the past three months, primarily driven by growing investor optimism related to the company's sole product, Lytenava, which is approved for the treatment of patients with wet age-related macular degeneration (wet AMD). OTLK's …

Resmed Inc Stock (RMD) Moved Up by 3.01% on Aug 10: Key Drivers Unveiled

Resmed Inc (RMD) stock rose by 3.01% on August 10th, driven by strong recurring revenue from its AirSense platform, positive clinical insights linking GLP-1 drugs to increased sleep apnea diagnoses, and solidified market share due to a competitor's regulatory issues. The company's performance is …

Cooper Companies Target of Unusually Large Options Trading (NASDAQ:COO)

Kaplan Fox & Kilsheimer LLP Alerts Embecta Corp. (NASDAQ: EMBC) Investors to a Securities Class Action Deadline on August 17, 2026

Kaplan Fox & Kilsheimer LLP has filed a class action lawsuit against Embecta Corp. (NASDAQ: EMBC) on behalf of investors who purchased securities between November 25, 2025, and May 4, 2026. The lawsuit alleges that Embecta's management knew or recklessly disregarded weaknesses in the …

ISRG Trades at a Premium P/E: Buy, Sell or Hold the Stock Now?

Intuitive Surgical (ISRG) is trading at a premium P/E ratio compared to its industry, despite a "D" Value Score. While the company delivered strong second-quarter 2026 results with significant revenue and earnings growth, the premium valuation raises concerns. Management's positive forward guidance, including sustained …

Best Momentum Stocks to Buy for August 10th

Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, August 10: Avnet, Inc. AVT: This electronics distribution company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 16.4% over …

Alcon earnings up next: Can revenue growth ease margin pressure?

Alcon is set to report its second-quarter earnings, with analysts expecting revenue growth but a potential decline in EPS, raising concerns about margin pressure. Investors will be closely watching if the company can meet revenue forecasts after a first-quarter miss and how management addresses …

L1 Capital Reports Sale of 174,721 Anteris Technologies Shares at $8.10 Each

L1 Capital Pty Ltd filed a Form 4 with the SEC on August 10, 2026, disclosing the sale of 174,721 shares of common stock in Anteris Technologies Global Corp. (NASDAQ: AVR). The transaction occurred on August 6, 2026. The article indicates a sale price …

Why Did Intuitive Surgical (NASDAQ:ISRG) Slide Despite Beating Expectations?

Intuitive Surgical (NASDAQ:ISRG) shares declined despite beating quarterly expectations. The slide was attributed to concerns over slowing domestic procedure growth, overshadowing the company's strong global growth outlook for the year. The article notes that recurring revenue is generated from instruments, accessories, and services used …

We Said These 4 Dividend Aristocrats Could Soar. Here’s How They Did, Plus 3 New Picks.

Quick Read ABBV surged 47% and BDX gained 26% over the past year, both decisively beating the market as their overlooked dividend growth drove outsized returns. All four original picks kept raising dividends regardless of price, with PG marking its 70th consecutive year of …

Why BioLife Solutions (BLFS) Is Up 7.8% After Swinging To Q2 Profitability And What's Next

BioLife Solutions (BLFS) reported a significant swing to profitability in Q2 2026, with sales up to US$28.47 million and net income of US$45.1 million, driven by its role as a supplier to the cell and gene therapy sector. The company is set to be …

Apple downgraded, HPE upgraded: Wall Street's top analyst calls

Apple downgraded, HPE upgraded: Wall Street's top analyst calls The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled by The Fly. Top Upgrades: Morgan …

DENTSPLY SIRONA Inc. (XRAY) Stock Forecasts

Morningstar has published an analyst report on DENTSPLY SIRONA Inc. (XRAY), stating that its weak recovery momentum remains unchanged due to soft volume impacting results. The report notes that Dentsply Sirona is one of the world’s largest manufacturers of dental equipment and supplies, formed …

Can Johnson & Johnson (JNJ) Challenge Intuitive Surgical (ISRG) After Ottava’s FDA Approval?

Johnson & Johnson (JNJ) has received FDA authorization for its OTTAVA robotic surgical system, marking its entry into the U.S. soft-tissue robotic surgery market. While OTTAVA features a differentiated table-integrated architecture, it faces a significant challenge from Intuitive Surgical (ISRG), which boasts a large …